Amicus Therapeutics, Inc. (NASDAQ:FOLD) shares decreased -1.99% in last trading session and ended the day at $6.90. FOLD has a return on assets of -38.50%. Amicus Therapeutics, Inc. (NASDAQ:FOLD) quarterly performance is -57.80%.
Khang & Khang LLP (the “Firm”) announces that a class action lawsuit has been filed against Amicus Therapeutics, Inc. (NASDAQ:FOLD). Investors who purchased or otherwise acquired shares between September 15, 2015 and October 1, 2015, inclusive (the “Class Period”) are encouraged to contact the Firm immediately to discuss their legal options.
Transition Therapeutics Inc. (NASDAQ:TTHI) ended the last trading day at $2.05. Company weekly volatility is calculated as 12.49% and price to cash ratio as 2.61. Transition Therapeutics Inc. (NASDAQ:TTHI) showed a weekly performance of 3.54%.
Transition Therapeutics Inc. (NASDAQ: TTHI) announced that its subsidiary, Transition Therapeutics Ireland Limited (“TTIL”), has completed a thorough review of the data related to the Phase 2/3 study of ELND005 in Alzheimer’s disease (“AD”) patients with moderate or severe agitation and aggression. The analysis identified a significant clinical benefit of ELND005 in AD patients with severe agitation and aggression, and will serve as the basis for patient selection in a Phase 3 clinical study. The review was performed in consultation with a group of key opinion leaders in the field of neuropsychiatry.
On 19 October, 3D Systems Corporation (NYSE:DDD) shares decreased -3.75% and was closed at $12.07. DDD EPS growth in last 5 year was 40.60%. 3D Systems Corporation (NYSE:DDD) year to date (YTD) performance is -63.28%.
On 12 October, 3D Systems Corporation (NYSE:DDD) announced the introduction of advanced cardiology training modules for the ANGIO Mentor(TM) VR simulator, together with a cardiovascular anatomical model product line that allows visualization of complex cardiovascular anatomy.
Apigee Corporation (NASDAQ:APIC) shares increased 6.94% in last trading session and ended the day at $10.63. APIC Gross Margin is 63.60% and its has a return on assets of -45.60%. Apigee Corporation (NASDAQ:APIC) quarterly performance is 6.83%.
On 13 October, Apigee Corporation (NASDAQ:APIC) announced that it is collaborating with Pivotal®, a company accelerating digital transformation and modern application development for enterprises, to create an integration of the Apigee Edge API management platform with Pivotal’s Cloud Foundry®.
22nd Century Group, Inc. (NYSEMKT:XXII) caters to the Healthcare space. Its weekly performance is 24.32%. On the last day of trading company shares ended up at $1.38. 22nd Century Group, Inc. (NYSEMKT:XXII) distance from 50-day simple moving average (SMA50) is 61.43%.
22nd Century Group, Inc. (NYSE MKT:XXII), announced an important new initiative in plant biotechnology: 22nd Century has entered into a new cannabis research collaboration with strategic partner Anandia Laboratories, Inc. (Anandia), based in Vancouver, Canada. As a part of this research collaboration, Anandia will develop and grow cannabis strains that express highly desirable characteristics and will lead to exciting commercialization opportunities. Dr. Paul Rushton, 22nd Century’s new Vice President of Plant Biotechnology, will have responsibility for this partnership with Anandia.
Leave a Reply